ABBV – AbbVie Inc.

Latest News & Stock Analysis

AbbVie Inc. is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. AbbVie strives to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health, and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. AbbVie was spun off from Abbott Laboratories in 2013, allowing it to focus on proprietary research and development. Its business model centers around the discovery, development, and commercialization of pharmaceuticals, with a strong emphasis on innovation and addressing unmet medical needs. For investors, AbbVie represents a significant player in the biopharmaceutical industry, known for its robust pipeline and commitment to tackling challenging health conditions. Stay informed with the latest news on ABBV, analysis of ABBV, and market trends to make informed investment decisions.